Skip to main content

Table 2 Baseline characteristics based on kidney function and trajectories (as described in Fig. 1)

From: Vitamin D metabolism in critically ill patients with acute kidney injury: a prospective observational study

Variable

Category

All

Kidney Function at day 5

Normal throughout

Developed new AKI

AKI II/III throughout

Renal recovery from AKI II/III

p-value

Missing %

n

137

52

11

51

23

  

Age

54 [47, 68]

50 [41, 69]

52 [51, 67]

57 [48, 66]

54 [48, 68]

0.776

0.7

Gender

Male

91 (66)

34 (65)

6 (55)

38 (75)

13 (57)

0.340

–

Female

46 (34)

18 (35)

5 (45)

13 (25)

10 (43)

Ethnicity

Asian

4 (3)

3 (6)

0

1 (2)

0

0.868

3.6

Black

9 (7)

2 (4)

0

5 (10)

2 (9)

Caucasian

118 (86)

43 (83)

11 (100)

43 (84)

21 (91)

Other

1 (1)

1 (2)

0

0

0

Missing

5 (4)

3 (6)

0

2 (4)

0

Season

Summer

68 (50)

27 (52)

6 (55)

20 (39)

15 (65)

0.201

0.0

Winter

69 (50)

25 (48)

5 (45)

31 (61)

8 (35)

CRP (Day 0) [mg/dL]

123 [54, 253]

97 [53, 144]

117 [84, 300]

161 [68, 305]

110 [43, 218]

0.037

11.7

Serum 25(OH)D on day 0 [nmol/L]

18 [10, 31]

20 [12, 34]

32 [14, 40]

14 [9, 26]

19 [9, 35]

0.076

6.6

Serum 1,25(OH)2D on day 0 [pmol/L]

50 [28, 68]

54 [33, 69]

63 [36, 106]

41 [26, 58]

36 [26, 56]

0.069

5.1

Calcium (Day 0) [mmol/L]

1.1 [1.1,1.2]

1.1 [1.1,1.2]

1.1 [1.1,1.2]

1.1 [1.1,1.2]

1.1 [1.1,1.2]

0.833

6.6

APACHE II score (on admission)

18 [14, 21]

14 [12, 17]

15 [12, 16]

21 [19, 23]

20 [17, 24]

 < 0.001

0.0

SOFA minus renal score (Day 0)

10 [7, 12]

8 [7, 10]

9 [6, 9]

11 [9, 13]

10 [8, 12]

 < 0.001

6.6

ICU mortality

25 (18)

4 (7.7)

1 (9)

18 (35.3)

2 (8.7)

0.002

-

Hospital mortality

31 (23)

5 (9.6)

1 (9)

22 (43.1)

3 (13)

 < 0.001

1.5

30-day mortality

31 (23)

5 (9.6)

1 (9)

23 (45.1)

2 (8.7)

0.001

5

Length of stay in ICU

14 [8, 23]]

10 [5, 15]

16 [10, 19]

18 [10, 30]

18 [8, 27]

0.010

29

  1. AKI Acute kidney injury, APACHE Acute physiology and chronic health evaluation, CRP C-reactive protein, ICU Intensive Care Unit, SOFA Sequential Organ Failure Assessment
  2. Significant variables are indicated in bold
  3. Results are reported as number (%), mean (%) or median [interquartile range]